Deletion of Atbf1/Zfhx3 In Mouse Prostate Causes Neoplastic Lesions, Likely by Attenuation of Membrane and Secretory Proteins and Multiple Signaling Pathways-Reference-Cited by-同舟云学术

Deletion of Atbf1/Zfhx3 In Mouse Prostate Causes Neoplastic Lesions, Likely by Attenuation of Membrane and Secretory Proteins and Multiple Signaling Pathways

Published:2014-05 Issue:5 Volume:16 Page:377-389
ISSN:1476-5586
Container-title:Neoplasia
language:en
Short-container-title:Neoplasia

Author:

Sun Xiaodong,Fu Xiaoying,Li Jie,Xing Changsheng,Frierson Henry F.,Wu Hao,Ding Xiaokun,Ju Tongzhong,Cummings Richard D.,Dong Jin-Tang

Publisher

Elsevier BV

Subject

Cancer Research

Reference93 articles.

1. Cloning and characterization of an ATBF1 isoform that expresses in a neuronal differentiation-dependent manner;Miura;J Biol Chem,1995

2. ATBF1-A protein, but not ATBF1-B, is preferentially expressed in developing rat brain;Ishii;J Comp Neurol,2003

3. Beta-amyloid increases the expression level of ATBF1 responsible for death in cultured cortical neurons;Jung;Mol Neurodegener,2011

4. Homeotic factor ATBF1 induces the cell cycle arrest associated with neuronal differentiation;Jung;Development,2005

5. Variants in ZFHX3 are associated with atrial fibrillation in individuals of European ancestry;Benjamin;Nat Genet,2009

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Somatic mutational landscape across Indian breast cancer cases by whole exome sequencing;Scientific Reports;2024-08-12

2. Evaluation of Potential Roles of Zinc Finger Homeobox 3 (Zfhx3) Expressed in Chondrocytes and Osteoblasts on Skeletal Growth in Mice;Calcified Tissue International;2024-08-01

3. ZFHX3 methylation in peripheral blood monocytes as a potential biomarker for pancreatic cancer detection;Pancreatology;2024-08

4. Spinocerebellar ataxia type 4 is caused by a GGC expansion in the ZFHX3 gene and is associated with prominent dysautonomia and motor neuron signs;Journal of Internal Medicine;2024-07-07

5. ZFHX3 acts as a tumor suppressor in prostate cancer by targeting FTO-mediated m6A demethylation;Cell Death Discovery;2024-06-13